Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle

Norbert Jost1, László Virág, Miklós Bitay

  • 1Department of Pharmacology and Pharmacotherapy, University of Szeged, H-6720 Szeged, Hungary.

Circulation
|September 1, 2005
PubMed
Abstract

Insights

Pharmacological block of the slow, delayed rectifier potassium current (IKs) has minimal impact on normal human ventricular muscle action potential duration. However, IKs plays a crucial role in limiting action potential prolongation when repolarization reserve is reduced.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pharmacology

Background:

  • The role of the slow, delayed rectifier potassium current (IKs) in human ventricular action potential duration (APD) is not fully understood.
  • Previous studies in animal models showed minimal APD changes with IKs blockade.

Purpose of the Study:

  • To investigate the effect of IKs blockade on normal human ventricular muscle APD.
  • To determine the role of IKs in conditions with attenuated repolarization reserve and sympathetic activation.

Main Methods:

  • Human ventricular muscle and myocytes were used.
  • Action potentials were measured using microelectrodes; membrane currents were measured using voltage-clamp.
  • IKs was blocked using chromanol 293B, L-735,821, and HMR-1556.
  • Repolarization reserve was attenuated with dofetilide and sympathetic activation was increased with adrenaline.

Main Results:

  • IKs blockers caused <12 ms change in APD in normal human ventricular muscle.
  • IKr blockers (sotalol, E-4031) markedly lengthened APD.
  • In conditions of attenuated repolarization reserve and sympathetic stimulation, HMR-1556 significantly increased APD by 14.7%.

Conclusions:

  • IKs block alone has little effect on normal human ventricular muscle APD.
  • IKs becomes critically important in limiting APD prolongation when repolarization reserve is compromised.

Related Concept Videos

Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...